Technology · Biochemistry & industrial biotech / Specialty & fine chemicals

Cosmetics, nutricosmetics & wellness

Fermentation-derived hyaluronic acid, recombinant collagen, bio-squalane and ingestible actives replacing animal- and petrochemical-derived cosmetic ingredients across China, the US and the EU.

Risk: low Cosmetics US · EU · CN Science: why it works → verified 2026-07-03 · 6 Sources (0 independent)

1 · What it gives

Cosmetics, nutricosmetics and the broader wellness industry are undergoing a structural shift from petrochemical- and animal-derived ingredients toward fermentation- and cell-culture-produced actives — hyaluronic acid, recombinant collagen, bio-identical squalane and skin-microbiome-targeted molecules. China’s Bloomage Biotech, formerly Bloomage Freda Biopharm, pioneered microbial-fermentation hyaluronic acid production starting in 2000 and has grown into one of the world’s leading HA suppliers, feeding both the medical and cosmetic segments. Giant Biogene, a Hong Kong-listed recombinant-collagen producer behind the consumer brand Kefumei, had its second recombinant-collagen implant medical device approved in China in 2026, extending its product line beyond topical cosmetics into medical aesthetics. In the US, Geltor’s fermentation platform has moved beyond conventional peptides with HumaColl™21 Select, a Type XXI collagen-based matrikine complex for topical beauty, and PrimaColl®, a vegan signaling-collagen ingredient now sold as a ready-to-drink supplement through a partnership with TOSLA. Biossance, launched by biotech firm Amyris in 2016, commercialized lab-made bio-identical squalane fermented from sugarcane-derived sucrose using engineered yeast, replacing shark-liver-derived squalane with a scalable, sustainable alternative. In Europe, Givaudan’s Active Beauty division continues to expand its biotech actives portfolio, including PrimalHyal NeuroYouth (a low-molecular-weight hyaluronic acid and amino acid complex targeting a newly characterized “neuro skin ageing” pathway) and Illuminyl™ 388 (a prebiotic skin-brightening ingredient).

The key directions of cosmetics, nutricosmetics and wellness biotech are:

Fermentation-derived actives: producing hyaluronic acid, squalane, collagen and other cosmetic ingredients via microbial or yeast fermentation instead of animal extraction or petrochemical synthesis.
Recombinant collagen: engineering yeast or bacteria to produce human-identical collagen types (e.g., Type XXI), avoiding the BSE risk of animal collagen and the fishy odor of marine collagen.
Skin-microbiome-targeted ingredients: pre-, pro- and postbiotic actives designed to support a balanced skin microflora rather than broadly antimicrobial formulations.
Nutricosmetics (ingestible beauty): oral collagen, biotin and ceramide supplements, increasingly paired with personalized formulation based on individual skin/gut data.

Sectoral value chain#

[Feedstock/Strain Selection] ──> [Precision Fermentation or Cell Culture] ──> [Purification & Formulation]
                                                                                       │
                                                                             (Efficacy/safety validation)
                                                                                       │
                                                                                       ▼
[Cosmetic/Nutricosmetic Product] <─── [Regulatory Registration]

Value chain levels#

Level	Description	Key inputs/outputs
1. Strain/feedstock selection	Selecting a production host (yeast, bacteria) or feedstock (sugarcane sucrose) for a target cosmetic active.	In: Microbial strain library, feedstock sugars. Out: Selected production strain/feedstock.
2. Precision fermentation	Fermenting the engineered host to produce the target molecule (HA, collagen, squalane).	In: Production strain, bioreactor, nutrients. Out: Crude fermentation broth containing the active.
3. Purification	Extracting and purifying the active ingredient from the fermentation broth.	In: Fermentation broth, chromatography/filtration equipment. Out: Purified cosmetic-grade active ingredient.
4. Formulation	Combining the purified active with a delivery system (cream, serum, capsule, drink).	In: Purified active, excipients/carriers. Out: Formulated cosmetic or nutricosmetic product.
5. Efficacy/safety validation	Testing the formulated product for safety and functional-claim substantiation.	In: Formulated product, clinical/consumer test protocols. Out: Validated efficacy/safety data package.
6. Regulatory registration & launch	Registering the product with the relevant regulator and launching to market.	In: Validated data package, regulatory filing. Out: Market-approved, launched product.

Cross-cutting technologies of the sector:

Microbial hyaluronic acid fermentation: producing HA via bacterial fermentation (e.g., Streptococcus zooepidemicus) rather than extraction from animal tissue, the dominant global HA production route.
Recombinant collagen expression: engineering yeast or E. coli to express specific human collagen types (e.g., Type XXI matrikines), yielding a molecule structurally identical to human collagen without animal-sourcing risk.
Fermentation-derived squalane: converting sugarcane-derived sucrose into bio-identical squalane via engineered yeast fermentation, replacing shark-liver oil as the traditional squalane source.

2 · What it replaces 3 · matched by industry

D1E–	Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their …	COSM
D3E2	Biodegradable scrub particles and exfoliants instead of polyethylene microbeads Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu …	COSM
D1E–	Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, …	COSM

3 · How to implement 6 steps

1
Production strain selection and engineeringStrains & cell lines
A production host (bacterial strain for HA, engineered yeast for collagen/squalane) is selected or genetically engineered to express the target molecule at commercially viable yield.
Who can do this step matched automatically
Bloomage Biotechnology China
✓ GMP 320 tons industrial scale
“[About Bloomage Biotech - 华熙生物 — Bloomage Biotech is a leading biotechnology and biomanufacturing company founded in 2000, focused on innovative synthetic biology with an …”
CABIO 嘉必优 (SSE 688089) China
✓ ISO 9001 600 tons
“Synthetic Biology”
BRAIN Biotech Germany
✓ ISO 9001 industrial scale
“Microbial Strain Development”
GenScript ProBio / Genscript China
✓ GMP industrial scale
“GenScript Biotech Corporation is a global biotechnology company founded in 2002 in New Jersey, USA, that provides life science research services, biologics development, and …”
2
FermentationFermentation & cultivation
The engineered strain is fermented at scale in a stirred-tank bioreactor, converting feedstock sugars into the target active ingredient over a multi-day fermentation cycle.
Who can do this step matched automatically
Bloomage Biotechnology China
✓ GMP 320 tons industrial scale
“Bloomage Biotechnology Corporation Limited (Bloomage Biotech, SSE STAR: 688363) is a China-based biotech/biomanufacturing company using fermentation and cross-link technologies to …”
Ajinomoto Japan
✓ GMP industrial scale
“It specializes in amino acid fermentation technology, applying it to seasonings, processed foods, frozen foods, and healthcare solutions.”
TurtleTree Singapore
industrial scale
“At TurtleTree, we are pioneering the future of health with our breakthrough product, LF+: the world’s first vegan lactoferrin created through cutting-edge precision fermentation …”
Loopworm India
✓ GMP 6,000 tonnes/year industrial scale
“At Loopworm, we are building the future of sustainable biomanufacturing.”
CABIO 嘉必优 (SSE 688089) China
✓ ISO 9001 600 tons
“生产与产业化：与合作伙伴（如中科院、美国嘉吉等）共同推进发酵法多不饱和脂肪酸的产业化、建立微生物油脂工厂、实现国内外市场布局。”
Jiangsu Trautec China
industrial scale
“2025-07-16 [喜讯｜创健医疗入选国家工信部第一批“AI+生物制造”典型案例企业动态新闻中心江苏创健医疗科技股份有限公司 — Jiangsu Trautec (创健医疗) is highlighted for being selected by China's Ministry of Industry and Information …”
3
Downstream purification and concentrationPurification & downstream
The fermentation broth is filtered, chromatographically purified and concentrated to yield a cosmetic-grade active ingredient meeting purity specifications.
Who can do this step matched automatically
Tsukishima Kikai Japan
✓ ISO 9001
“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
GenScript ProBio / Genscript China
✓ GMP industrial scale
“testing, including mass spectrometry and analytical high performance liquid chromatography”
Jiangsu Jland Biotech China
industrial scale
“Freeze-dried Eye Patch”
4
FormulationFormulation & blending
The purified active is combined with excipients, carriers and preservative systems appropriate to its final delivery form — cream, serum, injectable filler or oral supplement.
Who can do this step matched automatically
Yiming Biotechnology China
✓ GMP ✓ ISO 9001
“Ice Cream Premix Powder”
Zhejiang NHU Company China
✓ GMP industrial scale
“Looking ahead, NHU will remain committed to advancing nutrition and health by leveraging its biotechnology, chemical synthesis, and microencapsulation technology platforms.”
5
Efficacy and safety testingTesting & analytics
The formulated product undergoes safety testing and functional-claim substantiation studies required by the target market’s regulator.
Who can do this step matched automatically
Bloomage Biotechnology China
✓ GMP 320 tons industrial scale
“The company positions MitoEGT® as a mitochondria-targeting anti-aging ingredient with multiple efficacy studies, 38 patents, national metrology recognition, and plans to broaden …”
BRAIN Biotech Germany
✓ ISO 9001 industrial scale
“As a contract research organization (CRO), we provide smart, rapid, and effective solutions using cutting-edge technologies to drive customer success.”
GenScript ProBio / Genscript China
✓ GMP industrial scale
“ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”
6
Regulatory filing and market launchRegulatory & certification
The product is registered with the relevant national regulator (NMPA, FDA cosmetics framework, EU Cosmetics Regulation notification) and launched to market through retail, professional or digital-commerce channels.
Registration in Russia / EAEU: COSM — EAEU conformity bodies (Rospotrebnadzor for SGR)

4 · Who delivers

Matched suppliers (matched automatically)

Giant Biogene Holding	China	Distributor	active
Jiangsu Jland Biotech	China	Producer	active
Bloomage Biotechnology	China	Distributor	active
Jiangsu Trautec	China	Producer	active
UMAMI Bioworks	Singapore	Producer	active

In the services and supply catalogue 1 · paid service

Contract manufacturing (CMO/CDMO/toll)

Leading companies and institutes (from the brief)

Company / Institute	Country	Key products / platforms	Tech features	Status 2026
Bloomage Biotech	🇨🇳 China	Fermentation-derived hyaluronic acid	Microbial HA production since 2000, global supply scale	commercial
Giant Biogene	🇨🇳 China	Kefumei recombinant collagen	HKEX-listed, second collagen implant device approved (2026)	commercial
Winona	🇨🇳 China	Sensitive-skin barrier-repair skincare	Dermocosmetics/clinical-science brand positioning	commercial
Geltor	🇺🇸 USA	HumaColl™21 Select, PrimaColl®	Fermentation-based Type XXI collagen matrikines	commercial
Biossance	🇺🇸 USA	Neossance™-platform bio-squalane	Sugarcane-fermented bio-identical squalane	commercial
Givaudan (Active Beauty)	🇨🇭 Switzerland	PrimalHyal NeuroYouth, Illuminyl™ 388	Low-MW HA actives, prebiotic skin-brightening	commercial

5 · Rules & route to market

Route into Russia / EAEU: COSM · EAEU conformity bodies (Rospotrebnadzor for SGR)
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)

United States

The US cosmetics-biotech sector is shifting from “clean beauty” (natural-ingredient positioning) toward science-backed, fermentation-derived actives, alongside a large ingestible-wellness market.

fermentation-based collagen and squalane, ingestible-beauty growth, MoCRA regulatory reform#

Geltor: has extended its fermentation platform beyond conventional peptides with HumaColl™21 Select, a Type XXI collagen-based matrikine complex for topical beauty, and PrimaColl®, a vegan signaling-collagen ingredient now sold as a ready-to-drink supplement through a partnership with TOSLA.
Biossance: launched by biotech firm Amyris in 2016, commercialized lab-made bio-identical squalane fermented from sugarcane-derived sucrose using engineered Saccharomyces cerevisiae, positioning “clean beauty” as scientifically rigorous rather than purely natural-marketing-driven.
Regulatory reform: the Modernization of Cosmetics Regulation Act (MoCRA, 2022) introduced the first major overhaul of US cosmetics regulation in 85 years, adding mandatory facility registration and adverse-event reporting, while the FTC’s Green Guides require substantiation for “natural” and “sustainable” marketing claims.

European Union

The EU operates under the world’s strictest cosmetics framework, driving both ingredient innovation (fermentation, upcycling) and a “clean and circular beauty” positioning across its major national industries.

biotech active ingredients, strict regulatory framework, circular/upcycled sourcing#

Givaudan (Active Beauty division, Switzerland): continues to expand its biotech actives portfolio, including PrimalHyal NeuroYouth (a low-molecular-weight hyaluronic acid and amino acid complex targeting a newly characterized “neuro skin ageing” pathway) and Illuminyl™ 388 (a prebiotic skin-brightening ingredient).
Cosmetics Regulation (EC) 1223/2009: the world’s strictest cosmetics framework, banning animal testing since 2013 and tightly restricting CMR (carcinogenic/mutagenic/reprotoxic) substances and nanomaterials without specific safety assessment.
Microplastic restriction: the EU’s ban on intentionally added microplastics (in force since 2023, with the REACH Annex XV synthetic-polymer-microparticle restriction) has pushed the exfoliant and glitter segments toward biopolymer alternatives.

China

China is the world’s leading hyaluronic-acid producer and a fast-growing hub for recombinant collagen, with domestic brands increasingly competing on fermentation-based and dermatological science credentials.

hyaluronic acid fermentation leadership, recombinant collagen commercialization, domestic brand science positioning#

Bloomage Biotech: pioneered microbial-fermentation hyaluronic acid production starting in 2000 (as Bloomage Freda Biopharm) and has grown into one of the world’s leading HA suppliers across medical, cosmetic and food-grade segments.
Giant Biogene: a Hong Kong-listed recombinant-collagen producer behind the consumer brand Kefumei (可复美), which had its second recombinant-collagen implant medical device approved in China in 2026, extending beyond topical cosmetics into medical aesthetics.
Winona: a dermocosmetics brand focused on sensitive-skin barrier repair, positioning itself with a dermatological/clinical-science identity in the competitive domestic skincare market.
Regulatory tightening: China’s Cosmetics Supervision and Administration Regulation (2020) and its efficacy-claim evaluation rules (2021) require clinical substantiation for new cosmetic ingredients and functional claims, raising the bar for new-ingredient registration.

6 · Money: tenders & grants

Grant

Replacing hazardous substances in biocidal products

European Commission · EU

Sep 22, 2027
341 days

7 · Tech stack & innovations

Modern cosmetic-biotech ingredient production rests on the following technology stack:

Microbial fermentation for hyaluronic acid:
- Bacterial fermentation (e.g., Streptococcus zooepidemicus) produces hyaluronic acid at scale without animal-tissue extraction, the dominant global production route feeding both medical and cosmetic HA demand.
Recombinant collagen and matrikine expression:
- Engineered yeast or bacterial hosts express specific human collagen types and derived matrikine fragments (e.g., Type XXI), producing a molecule structurally identical to human collagen for topical or injectable use.
Engineered-yeast bio-squalane fermentation:
- Sugarcane-derived sucrose is fermented by engineered Saccharomyces cerevisiae to produce squalene, which is then hydrogenated to bio-identical squalane, replacing shark-liver oil as the traditional feedstock.

Sources 6 · 0 independent · 6 producer sites

Producers' own sites 6

Bloomage biotech producer checked 2026-07-03 · link not kept
Winona producer checked 2026-07-03 · link not kept
Geltor producer checked 2026-06-30 · link not kept
Biossance producer checked 2026-05-08 · link not kept
Givaudan producer checked 2026-03-31 · link not kept
Giant biogene producer checked 2026-07-03 · link not kept